Ginkgo Bioworks Holdings Inc. is a high-risk pharmaceutical company based in the United States of America. Specializing in cell programming, the company offers ESG-friendly services to various industries, including food and agriculture, pharmaceuticals, and industrial and specialty chemicals. With a Risk Rating Score of 33.4, Ginkgo Bioworks generates revenue primarily from its Biosecurity segment, which provides data analytics and services.